Hematologic tumors, Advanced solid tumors research hub

A First in Human open label study to evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Anti-Tumor Activity of VVD-130850 as Single Agent and in Combination with Checkpoint Inhibition in Participants with Advanced Solid and Hematologic Tumors.

Scientists are testing a new medicine called VVD-130850 in people with advanced cancers. They want to see if it's safe, how it works in the body, and if it can help fight cancer, both on its own and with other treatments.